Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Mathiesen DS, Lund A, Vilsboll T, Knop FK, Bagger JI
A notable phase 2 randomized controlled trial published in The Lancet examined exenatide (a GLP-1 agonist) in patients with moderate Parkinson's disease
discovered that a decrease in GSH content is a potential early activation signal for apoptosis, with subsequently generated oxygen free radicals promoting the occurrence of apoptosis
Pentadecapeptide BPC 157 as a therapy for neuroinflammation and traumatic brain injury
EP: Project administration, Writing review & editing
There are many possible neuroprotective benefits for those who may suffer from brain damage or even cognitive diseases like Alzheimers, such as preventing disease development and helping to recover brain function after traumatic injury
US$ 20.11
US$ 26.60
US$ 24.14
US$ 20.30
US$ 21.27
US$ 22.20
